APLM

Apollomics Inc. APLM

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,696 of 2,931

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Feb 14, 2027.

Revenue

$8.50M

Quarter to Dec 31

Net income

$-10.94M

Quarter to Dec 31

Operating margin

-128.7%

Quarter to Dec 31

Top Institutional Holders

as of Q3 2026
$334.1K total
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

Loading ratio trend…

APLM key financials by period

Reported revenue, net income and operating margin by fiscal year, from Apollomics Inc.'s annual filings on SEC EDGAR.

Apollomics Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$8.5M$-10.9M-128.7%
Source: APLM filings on SEC EDGAR →

APLM insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Apollomics Inc. (APLM): stock profile, AI score and financials

Apollomics Inc. (APLM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores APLM at 23.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,696 of 2,931 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Apollomics Inc. reports quarterly revenue of $8.5M, net income of $-10.9M, an operating margin of -128.7%. Top institutional holders of APLM by reported 13-F value include CITADEL ADVISORS, Clear Street Group, BOOTHBAY FUND MANAGEMENT, based on the most recent SEC filings. APLM trades on the Nasdaq exchange and files with the SEC under CIK 1944885. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate APLM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Apollomics Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1944885 →